Management of porphyria cutanea tarda in the setting of chronic renal failure: A case report and review

Journal of the American Academy of Dermatology

Volumn 42, Issue 4, 2000, Pages 645-652

  Shieh, Sherry ^a   Cohen, Joel L ^b   Lim, Henry W ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; COLESTYRAMINE; DEFEROXAMINE; ERYTHROPOIETIN; PORPHYRIN;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; FEMALE; HEMODIALYSIS; HUMAN; IRON OVERLOAD; KIDNEY TRANSPLANTATION; PHLEBOTOMY; PLASMAPHERESIS; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL;

EID: 0033928306     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.105504     Document Type: Article

References (37)

1. Bickers DR, Pathak MA, Lim HW. The porphyrias. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's Dermatology in general medicine; vol 2. 5th ed. New York: McGraw-Hill; 1999. p. 1766-803.
2. Kim JJ, Lim HW. Hexachlorobenzene and porphyria cutanea tarda. Arch Dermatol 1999;135:459-60.
3. Lim HW. Role of viral infection in porphyria cutanea tarda. Photodermatol Photoimmunol Photomed 1997;13:75-7.
4. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27:1661-9.
5. Elder GH, Worwood M. Mutations in the haemochromatosis (HFE) gene, porphyria cutanea tarda and iron overload. Hepatology 1998;27:289-91.
6. Poh-Fitzpatrick MB, Masullo AS, Grossman ME. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis. Arch Dermatol 1980;116:191-5.
7. Day RS, Eales L. Porphyrins in chronic renal failure. Nephron 1980;26:90-5.
8. Lichtenstein JR, Babb EJ, Felsher BF. Porphyria cutanea tarda in a patient with chronic renal failure on haemodialysis. Br J Dermatol 1981;104:575.
9. Rosenlof K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminum, and anaemia in patients on haemodialysis. Lancet 1990;335: 247-9.
10. Quereda C, Teruel JL, Lamas S, Marcen R, Matesanz R, Ortuno J. HLA antigens and serum ferritin in hemodialysis patients. Nephron 1987;45:104-10.
11. O'Reilly FM, Darby C, Fogarty J, Tormey W, Kay EW, Leader M, et al. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda. Arch Dermatol 1997;133:1098-101.
12. Ippen H. Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 1977;14:253-60.
13. Grossman ME, Bickers DR, Poh-Fitzpatrick MB, DeLeo VA, Harber LC. Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients. Am J Med 1979;67:277-86.
14. Ruggian JC, Fishbane S, Demento FJ, Maesaka JK, Frei GL. Porphyria cutanea tarda in a patient of chronic ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:397-402.
15. Riccioni N, Donati G, Soldani S, Scatena P, Arcabasso GD. Treatment of hemodialysis-related porphyria cutanea tarda with small repeated phlebotomies. Nephron 1987;46:125-7.
16. Sarkell B, Patterson JW. Treatment of porphyria cutanea tarda of end-stage renal disease with erythropoietin. J Am Acad Dernatol 1993;29:499-500.
17. Piazza V, Villa G, Galli F, Segagni S, Bovio G, Poggio F, et al. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda. Nephrol Dial Transplant 1992;7:438-42.
18. Peces R, de Salamanca E, Fontanellas A, Sanchez A, de laTorre M, Caparros G, et al. Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin. Nephrol Dial Transplant 1994;9:433-5.
19. Yaqoob M, Smyth J, Ahmad R, McClelland P, Fahal I, Kumar KAS, et al. Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin. Nephron 1992;60:428-31.
20. Poux JM, Demontis R, Cadranel JF, Ghazali A, Fievet P, Nordmann Y. Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: dramatic efficacy of small repeated phlebotomies. Am J Med 1997;103:163-4.
21. Anderson KE, Goeger DE, Carson RW, Lee SMK, Stead RB. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis. N Engl J Med 1990;322: 315-7.
22. Stevens BR, Fleischer AB, Piering F, Crosby DL. Porphyria cutanea tarda in the setting of renal failure. Arch Dermatol 1993;129: 337-9.
23. Stockenhuber F, Kurz R, Grimm G, Moser G, Balcke P. Successful treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine. Nephron 1990;55:321-4.
24. Praga M, de Salamanca RE, Andres A, Nieto J, Oliet A, Perpina J, et al. Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine. N Engl J Med 1987;316:547-8.
25. Poh-Fitzpatrick MB, Sosin AE, Bemis J. Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients. J Am Acad Dermatol 1982;7:100-4.
26. Scholnick PL, Epstein J, Marver HS. The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol 1973;61:226-32.
27. Parrilla JG, Ortega R, Pena ML, Rodicio JL, de Salamanca, RE, Olmos A, et al. Porphyria cutanea tarda during maintenance haemodialysis. Br Med J 1980;280:1358.
28. King J, Day RS, Milne FJ, Bezwoda WR, Viljoen JD, Kramer S. Delayed onset of overt porphyria cutanea tarda in a patient on long-term haemodialysis: a case report. S Afr Med J 1983;63: 743-6.
29. Disler P, Day R, Burman N, Blekkenhorst G, Eales L. Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchange. Am J Med 1982;72:989-93.
30. Suga C, Ikezawa Z. Porphyria cutanea tarda in hemodialyzed patients. Nippon Rinsho 1995;53:1484-90.
31. Toriyama T, Kawahara H. Small volume plasma exchange therapy in patients with porphyria cutanea tarda on maintenance hemodialysis. Nippon Rinsho 1992;50(Suppl):423-8.
32. Poh-Fitzpatrick MB, Bellet N, DeLeo VA, Grossman ME, Bickers DR. Porphyria cutanea tarda in two patients treated with hemodialysis for chronic renal failure. N Engl J Med 1978;299: 292-4.
33. Carson RW, Dunnigan EJ, DuBose TD, Goeger DE, Anderson KE. Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. J Am Soc Nephrol 1992;2:1445-50.
34. Stathers GM. Porphyrin-binding effect of cholestyramine: results of in-vitro and in-vivo studies. Lancet 1966;2:780-3.
35. Tishler PV, Gordon RJ, O'Connor JA. The adsorption of porphyrins and porphyria precursors by sorbents: a potential therapy for the porphyrias. Methods Find Exp Clin Pharmacol 1982; 4:125-31.
36. Tishler PV, Gordon BJ. Sorbent therapy of porphyrias II. Experimental plasma haemoperfusion with a commercial charcoal cartridge. Methods Find Exp Clin Pharmacol 1983;5:185-91.
37. McColl KE, Simpson K, Laiwah AY, Thompson GG, McDougall A, Moore MR. Hemodialysis-related porphyria cutanea tarda: treatment failure with charcoal hemoperfusion. Photodermatology 1986;3:169-73.